ClinicalTrials.gg
RecruitingNCT06380504R-SWITCHUpdated Sep 24, 2026

Increasing the Coverage of Severe Acute Malnutrition (SAM) Treatment in Ethiopia

An interventional study of R-SWITCH integrated intervention package in Acute Malnutrition, Severe, Malnutrition, Child and Wasting, sponsored by International Food Policy Research Institute. Recruiting at 1 site in Ethiopia. Open to participants aged 6 Months to 5 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-24.

Sponsored by International Food Policy Research Institute · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started May 2024; still recruiting 2 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
1,080
Allocation
Randomized
Ages
6 Months to 5 Years
Sex
All
01

Study summary

The R-SWITCH intervention aims to address the low coverage of treatment for severe wasting (SAM) by leveraging existing community groups to deliver an integrated package focused on prevention, screening, referral, and treatment of SAM. It includes behavior change communication on child nutrition and health, active screening, improved passive screening at health posts, and follow-up of referred cases and those enrolled in outpatient treatment programs (OTP). The primary objectives of the R-SWITCH studies are to assess the intervention's impact on OTP coverage, identify implementation barriers and facilitators, and evaluate its cost-efficiency and cost-effectiveness.

Read the detailed description

Despite the high mortality risk of severe wasting (also referred to as severe acute malnutrition or SAM), only a small proportion of children with severe wasting are currently identified and admitted to available outpatient treatment programs (OTP). In 2020, an estimated 4.9 million children with severe wasting received treatment, approximately a third of the total burden. Outside of humanitarian settings, this proportion is even lower (estimated to be around 15%). These figures highlight the urgent need to increase treatment coverage to meet the Sustainable Development Goals (SDG), which aim to reduce the prevalence of child wasting to less than 5% by 2025 and less than 3% by 2030. The continuum of care for SAM, from case identification, referral to treatment, and post-treatment follow-up, is hampered by several barriers including caregiver lack of awareness on the risks and treatment services of SAM, stigma related to SAM, poor accessibility to treatment, frequent stockouts of treatment inputs, and the overall workload faced by first-line health workers.

The R-SWITCH intervention will leverage existing community groups to deliver an integrated package aimed at preventing SAM through behavior change communication (BCC) on child nutrition and health, increasing wasting screening coverage through active screening, family-led MUAC and improved passive screening health posts, increasing treatment coverage through follow-up of earlier referred cases, cases enrolled in OTP, and children who completed OTP and recovered.

The primary objectives of the R-SWITCH studies are:

  • To assess the impact of the R-SWITCH intervention on SAM OTP coverage
  • To identify implementation barriers and facilitators
  • To assess the cost-efficiency and cost-effectiveness of the intervention package and services
02

Conditions studied

  • Acute Malnutrition, Severe
  • Malnutrition, Child
  • Wasting

Keywords

  • Outpatient Therapeutic Feeding Program
  • Treatment
  • Screening
  • Wasting
  • Severe acute malnutrition
03

In context

Severe Acute Malnutrition

82 studies on the registry are indexed under Severe Acute Malnutrition; 13 are open to participants now.

This study's planned enrollment of 1,080 is above the median of 400 across 69 interventional studies indexed under Severe Acute Malnutrition.

Browse Severe Acute Malnutrition studies →

Lead sponsor

International Food Policy Research Institute is the lead sponsor of 37 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months to 5 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Child 6-59 months of age
  • Suffering from SAM (defined as MUAC \< 115mm or presence of bilateral pitting edema or Weight-for-Length Z-score \<-3) OR currently enrolled in SAM OTP

Exclusion criteria

Exclusion Criteria:

- Anthropometric malformation or being handicapped which hampers anthropometric measurements.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,080 participants (estimated)

Study arms

  • No intervention
    Standard of Care

    * Usual screening of wasting by health extension workers (HEW) using MUAC * Previous introduction of Family-led MUAC (not maintained) * Behavior Change Communication (BCC) offered by Health extension worker (low intensity) * Treatment of SAM at health post or health center * Follow-up of SAM OTP defaults through home visits by HEW (very low intensity)

  • Experimental
    R-SWITCH integrated intervention package

    1. Monthly group meetings of AFD community groups 2. Introduction of weight-for-age Z-score \<-3 as an additional screening criterion 3. Promotion of Family-led MUAC screening and SAM awareness to fathers, community and religious leaders 4. Follow-up and counselling during home visits by AFD leaders 5. Strengthening communication between HEW and AFDs

    Behavioral: R-SWITCH integrated intervention package

Interventions

  • BehavioralR-SWITCH integrated intervention package

    1. Monthly group meetings of Alliance for Development (AFD) community groups) and their members (caregivers of children 0-59 months of age): * Introduction and refresher of Family-led MUAC * Active screening of wasting by AFD * Group SBCC on Infant and Young Child Feeding (IYCF), health and Water, Sanitation and Hygiene (WaSH) with a focus on SAM * Promotion of health services such as GMP 2. Introduction of weight-for-age Z-score \<-3 as screening criterion for passive screening by health extension workers at any contact with children (e.g. during GMP) 3. Promotion of Family-led MUAC screening and SAM awareness to fathers during male agricultural/pastoralist extension activities and by community and religious leaders (creating social support) 4. Follow-up and counselling during home visits by AFD leaders of i) earlier referred cases of SAM, ii) cases enrolled in SAM OTP, iii) and recovered SAM cases discharged from OTP 5. Strengthening communication between HEW and AFDs

06

What researchers measure

Primary outcomes

  1. Period prevalence of SAM OTP treatment coverage in children 6-59 months of age

    Defined as the proportion of children with Severe Acute Malnutrition (SAM) or enrolled in the SAM Outpatient Therapeutic program (OTP) that are "under treatment". * SAM is defined as a Mid-Upper Arm Circumference \<115mm or a weight-for-height Z-score \<-3 (relative to the World Health Organization (WHO) 2006 growth standards) or presence of bilateral pitting edema. * "Under treatment" is defined as: * the caregiver acknowledging the child is enrolled in a SAM OTP AND * the child was fed ready-to-use therapeutic food (RUTF) over the last three days AND * the caregiver can either show at least one full RUTF sachet OR more than one empty RUTF sachet.

    Time frame: After 24 months of program implementation

Secondary outcomes

  1. Point prevalence of SAM OTP treatment coverage in children 6-59 months of age

    Defined as the proportion of children with SAM at the time of the survey that are under treatment (see definition under primary outcome

    Time frame: After 24 months of program implementation

  2. Period prevalence of SAM OTP treatment coverage in the subgroup of treatment eligible children 6-59 months of age

    Defined as the proportion of children with Severe Acute Malnutrition (SAM) or Severe underweight (weight-for-age Z-score \<-3) or enrolled in the SAM Outpatient Therapeutic program (OTP) that are "under treatment". * SAM is defined as a Mid-Upper Arm Circumference \<115mm or a weight-for-height Z-score \<-3 (relative to the WHO 2006 growth standards) or presence of bilateral pitting edema. * "Under treatment" is defined as: * the caregiver acknowledging the child is enrolled in a SAM OTP AND * the child was fed ready-to-use therapeutic food (RUTF) over the last three days AND * the caregiver can either show at least one full RUTF sachet OR more than one empty RUTF sachet.

    Time frame: After 24 months of program implementation

  3. Screening coverage of SAM

    Defined as the proportion of children aged 6-59 months with SAM screened for wasting over the last 30 days (as reported by the caregiver)

    Time frame: After 24 months of program implementation

  4. Screening coverage of severe underweight

    Defined as the proportion of children aged 6-59 months with severe underweight (weight-for-age Z-score \<-3 relative to WHO 2006 growth standard) screened over the last 30 days (as reported by the caregiver)

    Time frame: After 24 months of program implementation

  5. Platform specific screening coverage of SAM

    Defined as the proportion of children aged 6-59 months with SAM screened for wasting over the last 30 days (as reported by the caregiver): * by Family-led MUAC ( screening by family members using a MUAC tape) * during growth monitor promotion (GMP) consultations * during Integrated management of childhood illness consultations

    Time frame: After 24 months of program implementation

  6. Growth Monitoring Promotion (GMP) consultation attendance

    Defined as the proportion of children aged 6-59 months with SAM that attended GMP over the last 30 days (as reported by the caregiver).

    Time frame: After 24 months of program implementation

  7. AFD group meeting attendance

    Defined as the proportion of of children aged 6-59 months with SAM that attended the monthly AFD group contact over the last 30 days (as reported by the caregiver).

    Time frame: After 24 months of program implementation

  8. AFD home visit coverage

    Defined as the proportion of children aged 6-59 months with SAM and children enrolled in SAM OTP that received a home visit by an AFD leader/member over the last 30 days (as reported by the caregiver).

    Time frame: After 24 months of program implementation

  9. Prevalence of SAM

    Defined as the proportion of children aged 6-59 months with SAM (defined as WHZ \<-3 or a MUAC \< 115 mm or the presence of bilateral pitting edema). To calculate WHZ scores the 2006 WHO growth reference will be used

    Time frame: After 24 months of program implementation

  10. Prevalence of wasting

    Defined as the proportion of children aged 6-59 months with wasting (defined as WHZ \<-2 or a MUAC \< 125 mm or the presence of bilateral pitting edema). To calculate WHZ scores the 2006 WHO growth reference will be used

    Time frame: After 24 months of program implementation

  11. Prevalence of stunting

    Defined as the proportion of children aged 6-59 months with stunting (defined as height-for-age Z-scores (HAZ) \<-2 or a MUAC \< 125 mm or the presence of bilateral pitting edema). To calculate HAZ scores the 2006 WHO growth reference will be used

    Time frame: After 24 months of program implementation

  12. Prevalence of underweight and severe underweight

    Defined as the proportion of children aged 6-59 months with underweight (defined as weight-for-age Z-scores (WAZ) \<-2 ) and severe underweight (defined as WAZ \<-3 ). To calculate WAZ scores the 2006 WHO growth reference will be used

    Time frame: After 24 months of program implementation

  13. Mean height-for-age Z-score (HAZ)

    In 6-59 months old children. To calculate HAZ scores the 2006 WHO growth reference will be used

    Time frame: After 24 months of program implementation

  14. Mean weight-for-height Z-score (WHZ)

    In 6-59 months old children.To calculate WHZ scores the 2006 WHO growth reference will be used

    Time frame: After 24 months of program implementation

  15. Mean weight-for-age Z-score (WAZ)

    In 6-59 months old children.To calculate WAZ scores the 2006 WHO growth reference will be used

    Time frame: After 24 months of program implementation

  16. Mean mid-upper arm circumference (MUAC)

    In 6-59 months old children.

    Time frame: After 24 months of program implementation

  17. Caregiver's knowledge related to breastfeeding, complementary feeding,child health and hygiene, the condition of severe acute malnutrition, outpatient therapeutic programs, screening of wasting

    Presented as a total standardized score and by knowledge domain

    Time frame: After 24 months of program implementation

  18. Vaccination coverage

    Proportion of children aged 6-18 months with SAM or enrolled in SAM OTP who received all age-recommended immunizations

    Time frame: After 24 months of program implementation

  19. Introduction of (semi) solid and soft complementary foods

    The proportion of children 6-8 months of age who consumed (semi) solid and soft complementary foods during the previous day

    Time frame: After 24 months of program implementation

  20. Minimum dietary diversity in infants and young children (6-23 mo)

    The proportion of study children aged 6-23 months who consumed at least 5 of the 8 food groups (including breast milk) during the previous day

    Time frame: After 24 months of program implementation

  21. Nr of food groups consumed by infants and young children (6-59 mo)

    The mean number of food groups consumed during the previous day by study children aged 6-59

    Time frame: After 24 months of program implementation

  22. Minimum meal frequency in infants and young children

    Defined as the proportion of study children who had eaten during the previous day: 2 meals for breastfed children 6-8 months, 3 meals for breastfed children 9-23 months, or 4 meals for non-breastfed children 6-23 monthsMinimum meal frequency for children, defined as the proportion of children who had eaten the day before the survey: 2 meals for breastfed children 6-8 months, 3 meals for breastfed children 9-23 months, or 4 meals for non-breastfed children 6-23 months.

    Time frame: After 24 months of program implementation

  23. Minimum acceptable diet in infants and young children

    Defined as the proportion of study children aged 6-23 months with both minimal dietary diversity and minimal meal frequency during the previous day

    Time frame: After 24 months of program implementation

  24. Continuous breastfeeding 12-23 months

    Defined as the proportion of children aged 12-23 months breastfed during the previous day

    Time frame: After 24 months of program implementation

  25. Egg and/or flesh food consumption

    Proportion of children 6-23 months of age who consumed egg and/or flesh food during the previous day

    Time frame: After 24 months of program implementation

  26. Sweet beverage consumption

    Proportion of children 6-23 months of age who consumed a sweet beverage during the previous day

    Time frame: After 24 months of program implementation

  27. Zero vegetable or fruit consumption consumption

    Proportion of children 6-23 months of age who did not consume any vegetables or fruits during the previous day

    Time frame: After 24 months of program implementation

  28. Minimum milk feeding frequency for non-breastfed children

    Proportion of non-breastfed children 6-23 months of age who consumed at least two milk feeds during the previous day

    Time frame: After 24 months of program implementation

  29. Weight-for-length Z-score and MUAC at Severe Acute Malnutrition (SAM) Outpatient Therapeutic Feeding program (OTP)

    Weight-for-length Z-score (relative to the 2006 WHO reference) and MUAC(mm)

    Time frame: 24 months from baseline until endline of the study

  30. SAM OTP adherence

    Defined as the proportion of cases enrolled to SAM OTP who received timely treatment from dedicated services (health center or health post) until anthropometric recovery

    Time frame: 24 months from baseline until endline of the study

  31. Weight gain rate during SAM OTP

    Defined as the weight gain during SAM OTP divided by the length of treatment and divided by the child's weight

    Time frame: 24 months from baseline until endline of the study

  32. SAM OTP outcomes (drop-out, death, transfer, non-response rates)

    Among cases admitted to SAM OTP

    Time frame: 24 months from baseline until endline of the study

  33. SAM OTP duration

    Defined as the number of days spent in SAM OTP (from admission to discharge)

    Time frame: 24 months from baseline until endline of the study

07

Study locations

1 of 1 sites recruiting
  • Kersa and Jeldessa woredas
    Jimma, Ethiopia
    Recruiting
    • Lieven Huybregts, PhD · Principal investigator
    • Tefera Belachew, PhD · Principal investigator
08

References and documents

Publications

  • Biru B, Huybregts L, Tamiru D, Areb M, Haddis A, Fall T, Toure M, Belachew T. Barriers and Factors Associated With Treatment Coverage of Severe Acute Malnutrition Among Children 6-59 Months in Agrarian and Pastoralist Areas of Ethiopia. Matern Child Nutr. 2026 Jul;22(3):e70219. doi: 10.1111/mcn.70219. PubMed 42381597 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2024 (actual). Primary completion is estimated for Sep 2026, 28 months after the start.

Of 32 non-industry interventional studies with no phase under Severe Acute Malnutrition, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 28. This study's planned 28 months is above that.

Counting every sponsor, half of 32 studies reached it within 19 months; a quarter within 11 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 18, 2024
First posted
Apr 24, 2024
StartActual
May 2, 2024
Primary completionEst.
Sep 30, 2026
CompletionEst.
Jun 30, 2027
Last update
Sep 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06380504
Lead sponsor
International Food Policy Research Institute
Collaborators
Ethiopian Public Health Association, UNICEF
Responsible party
Sponsor
First posted
Apr 24, 2024
Start date
May 2, 2024
Primary completion
Sep 30, 2026 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Sep 24, 2026

Study contacts

Lieven Huybregts, PhD
Contact
l.huybregts@cgiar.org
202 862-6481 ext. +1
Alemayehu Haddis, PhD
Contact
alemayehuh@etpha.org
Lieven Huybregts, PhD
principal investigator · International Food Policy Research Institute
Tefera Belachew, PhD
principal investigator · Ethiopian Public Health Association

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion